LOS ANGELES : In the latest development, researchers in University of California (UC), Davis in the US have created a novel antibody that can directly interfere with and block the cell-to-cell transmission ability of SARS-CoV-2.
The approach, described recently in the journal Microbiology Spectrum, could be added to existing SARS-CoV-2 antibody cocktails for greater function against emerging variants. "We developed an approach that interferes with the transmission chain of SARS-CoV-2," said senior author of the study Jogender Tushir-Singh from the University of California (UC), Davis in the US.
The antibody, FuG1, targets the enzyme Furin, which the virus uses for its efficient chain of infections in human cells. "The Covid-19 vaccines are a great lifesaver in reducing hospitalisations and severe illness.
Yet, we are now learning that they may not be as effective in controlling the transmissibility of the virus," Tushir-Singh said.